![David Alastair Smith](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Alastair Smith
Voorzitter bij
THERACRYF PLC
Vermogen: 2 M $ op 30-06-2026
Profiel
David Alastair MacLaughlin Smith was the founder of Avacta Group Plc, founded in 2004, where the title held was Chief Executive Officer & Executive Director from 2005 to 2024.
Current jobs include Non-Executive Chairman at SPARTA Biodiscovery Ltd., Non-Executive Chairman at TheraCryf Plc starting in 2025, and Independent Non-Executive Director at Thalia Therapeutics Plc starting in 2025.
Former jobs include Chief Executive Officer & Director at Avacta Life Sciences Ltd., Director-Institute of Molecular Biophysics at the University of Leeds, and Director at TheraGenetics Ltd. Education includes undergraduate and doctorate degrees from The University of Manchester.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
AVACTA GROUP PLC 0,33% | 04-06-2025 | 1.565.100 ( 0,33% ) | 2 M $ | 30-06-2026 |
THERACRYF PLC 0,19% | 31-03-2025 | 4.000.000 ( 0,19% ) | 11 400 $ | 30-06-2026 |
Actieve functies van David Alastair Smith
| Bedrijven | Functie | Begin |
|---|---|---|
| THALIA THERAPEUTICS PLC | Directeur/Bestuurslid | 08-01-2025 |
| THERACRYF PLC | Voorzitter | 19-02-2025 |
Sparta Biodiscovery Ltd.
 Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Voorzitter | - |
Eerdere bekende functies van David Alastair Smith
| Bedrijven | Functie | Einde |
|---|---|---|
| AVACTA GROUP PLC | Oprichter | 01-05-2024 |
Avacta Life Sciences Ltd.
 Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | - |
TheraGenetics Ltd.
 TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Directeur/Bestuurslid | - |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van David Alastair Smith
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
49
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Evgen Pharma Plc
 Evgen Pharma Plc Medical/Nursing ServicesHealth Services Engages in the development of pharmaceutical products and focus on cancer & neurological disease | Health Services |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
TheraGenetics Ltd.
TheraGenetics Ltd. Pharmaceuticals: MajorHealth Technology Manufactures brachytherapy seeds for prostate and localized cancers | Health Technology |
Avacta Life Sciences Ltd.
Avacta Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
N4 Pharma Plc
 N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Sparta Biodiscovery Ltd.
Sparta Biodiscovery Ltd. Medical SpecialtiesHealth Technology Manufactures instruments for chemical analysis and pharmaceutical research | Health Technology |
